Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

Treatment of Pain Sclf rcgulatlon IC'Cbn!

qUN
3.11Xlol)1ica
nntldcprca~nQ
corta cduc~tion,l"Xplanationrc-p:iin

"-.Dtsct................
Serotonin(TCA'1)
norq,lnq,brinc Peridur.11 opfatc1
cnkcph:illa1 TESS

' NSAID \
spin~ cord 1timul:ition
~- SPmtagoni1t1
GABA
Clonldine
b)-polulul■I - - - - lllllalllD
Systenuc opi:itcs _ . - Pcridur.11 loc3l mn1hctk1
NSAIDs
I .-- Peripheral ilCl'\'C block
ilL___ Painful
~I! ·· Jtlmulus

Antibi111mine1
slucoconicold1
Sympathetic sanslfon NSA1D1
btocbde - loc:il ancathctfc infihtatfon
muscle iela.unil
SP antagoni1i•
Vi1cer:1 -.. .- V11odilaton serotonin antagonisll
blood vcs1cl1 rmal-do1e dop.unine

Handbook ofcritical-care pain 111ii1icigen1e;11,,i994


OLadder
om From Cancer Pain
Step 3: Opioid for Moderate to Severe Pain
:tNonopiaid
Pain i,en;mns ~Juv.1n1
ori Ing
Step 2: Opioid for Mild to MGldetrate •
+ "oid
Pain ·st1ng · ~Juwnt
ori~ming
Step 1: Nanap· .
~luvanl

Pain , 1990. Used with aermis.sion.


Cell 1\lembrane
Phospbolipids Cyotkincs
Growth Factors
Endotoxin
Angiotcnsin II reactive 02 molecules
Steroids
Bradykinin
l\1E Phospholipase A 2 glucoconicoids ·1(
Vasopressin
COX-2 Cyclooxygenasc 2
Arachidonic Acid Cyclooxygenase I

Lipooxygenase xygenase

5-Iiydroperoxyeicosatetraenoic Acid
Cyclic Endoperoxides
5-HPETE

r
5-H ydroeicosatetraenoic
Acid
Leukotrienes

(5-HETE)

Eicosanoid Prostanoid
Pathway Pathway
Titrate Opioids to Effects

Dose
of Pain free, trust the patient
Opioid

Time

AlcQuay H a11d 1.\t/00,-e A, An e11ide11ce-based ,-esourceJo,-pain ,-e/ief, 1998


Unconsciousness
Apnea
Respiratory depression
Increased.sedation
Increased nausea, vomiting

Base-line '""'"'lo&S-wsia

Incnasing~opioidtdose
Pain Cycle With P Medications
Patient PAIN
\rariables
a
Sedation a
Call for Nurse
••
Relief
(Analgesia) ♦a 13 13 13 ■■ 19 19

PCA
Nurse Responds

Body
.~bsorbs
U ptake/ The Drug

~
Distibution
Va.-iables
· · ter
Medications -
Sim Out Medications

~ Nursing Vaiiablcs
Prepare Medications
Gra,·es et al,Am1 Int i\Jed,19S3
P1·ofile of Plasma Drug Levels
During PCA Therapy
Rl;!spiratory d~pr~ssion
C

·--0c:-: St!clation
--
~

( 'J ..........
..
...
... ... ...-. ....
..
.... ....
.
.......
..
.. ..
...
....
.. . . •..
.......... .: ....
...... .......
.
.: :.
.. . .
-u ..... ..... ... .... ... .... ... ... ... .....
CJ
... ... .. ..
,-
.:. ..... .. ..
0 .. .. .. .. .. .
....
... .. . .. .. ... .. ...
. .. .... ....
.: . . ...
.
... .
... :. ... . ... ... .. ... ..
...
·--
...... : . .. .. . .
... . ..
....· ..
Q.)
:. ....
ca . .... .. ..:
-.;
:.. .:
.... ..-. .. .
- .....
4""\

0
-0
0
-co
0 Pain

Time

You might also like